XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets, Parent - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,793 $ 368
Restricted cash and cash equivalents 89 86
Accounts receivable    
Customer accounts receivable (net of allowance for credit losses of $55 and $56 as of September 30, 2024 and December 31, 2023, respectively) 1,208 1,934
Other accounts receivable (net of allowance for credit losses of $6 and $5 as of September 30, 2024 and December 31, 2023) 557 917
Mark-to-market derivative assets 632 1,179
Inventories, net    
Natural gas, oil, and emission allowances 209 284
Materials and supplies 1,263 1,216
Renewable energy credits 700 660
Other 2,819 1,655
Total current assets 9,270 8,299
Property, plant, and equipment (net of accumulated depreciation and amortization of $17,972 and $17,423 as of September 30, 2024 and December 31, 2023, respectively) 20,892 22,116
Deferred debits and other assets    
Nuclear decommissioning trust funds 17,694 16,398
Investments 494 563
Goodwill 420 425
Mark-to-market derivative assets 732 995
Deferred income taxes 35 52
Other 2,297 1,910
Total deferred debits and other assets 21,672 20,343
Total assets [1] 51,834 50,758
Current liabilities    
Short-term borrowings 0 1,644
Long-term debt due within one year 1,034 121
Accounts payable and accrued expenses 2,685 2,612
Mark-to-market derivative liabilities 502 632
Renewable energy credit obligation 909 972
Other 322 338
Total current liabilities 5,452 6,319
Long-term debt 7,378 7,496
Deferred credits and other liabilities    
Deferred income taxes and unamortized ITCs 3,554 3,209
Asset retirement obligations 12,322 14,118
Pension obligations 867 1,070
Non-pension postretirement benefit obligations 774 732
Spent nuclear fuel obligation 1,349 1,296
Payables related to Regulatory Agreement Units 4,828 3,688
Mark-to-market derivative liabilities 341 419
Other 2,028 1,125
Total deferred credits and other liabilities 26,063 25,657
Total liabilities [1] 38,893 39,472
Commitments and contingencies (Note 13)
Shareholders' equity    
Common stock (No par value, 1,000 shares authorized, 313 shares and 317 shares outstanding as of September 30, 2024 and December 31, 2023, respectively) 11,379 12,355
Retained earnings (deficit) 3,325 761
Accumulated other comprehensive income (loss), net (2,134) (2,191)
Total shareholders’ equity 12,570 10,925
Noncontrolling interests 371 361
Total equity 12,941 11,286
Total liabilities and equity $ 51,834 $ 50,758
[1] Our consolidated assets include $3,992 million and $3,355 million at September 30, 2024 and December 31, 2023, respectively, of certain VIEs that can only be used to settle the liabilities of the VIE. Our consolidated liabilities include $982 million and $990 million at September 30, 2024 and December 31, 2023, respectively, of certain VIEs for which the VIE creditors do not have recourse to us. See Note 15 — Variable Interest Entities for additional information.